Clinical Trials List
2020-07-01 - 2027-12-31
Phase III
Recruiting8
ICD-10C50.911
Malignant neoplasm of unspecified site of right female breast
ICD-10C50.912
Malignant neoplasm of unspecified site of left female breast
ICD-10C50.919
Malignant neoplasm of unspecified site of unspecified female breast
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9174.9
Malignant neoplasm of female breast, unspecified
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- KA-WAI TAM Division of General Surgery
- TSU-YI CHAO Division of Hematology & Oncology
- Yao-Yu Hsieh Division of Hematology & Oncology
- CHIN-SHENG HUNG Division of General Surgery
- Wei-Hong Cheng Division of Hematology & Oncology
- HUI-WEN LIU Division of Hematology & Oncology
- Tsu-Yi Chao 未分科
- 蘇智銘 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ta-Chung Chao Division of Hematology & Oncology
- Jiun-I Lai Division of Radiation Therapy
- Yi-Fang Tsai Division of General Surgery
- 賴亦貞 Division of Radiology
- 陳彥蓁 Division of General Surgery
- 林燕淑 Division of General Surgery
- 馮晉榮 Division of General Surgery
- Chi-Cheng Huang Division of General Surgery
- 邱仁輝 Division of General Surgery
- Chun-Yu Liu Division of Hematology & Oncology
- 郭懿萱 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ya-Ting Hsu Division of Hematology & Oncology
- Wu-Chou Su Division of Hematology & Oncology
- Yao-Lung Kuo Division of General Surgery
- Kuo-Ting Lee Division of General Surgery
- Jui-Hung Tsai Division of Hematology & Oncology
- 楊舜如 Division of Hematology & Oncology
- Chun-Hui Lee Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chen-Teng Wu Division of General Surgery
- 黃至豪 Division of General Surgery
- Chih-Jung Chen Division of General Surgery
- Yao-Chung Wu Division of General Surgery
- Liang-Chih Liu Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- MING-YANG WANG Division of General Surgery
- YEN-SHEN LU Division of Hematology & Oncology
- 陳怡君 Division of Hematology & Oncology
- 林柏翰 Division of General Internal Medicine
- 張端瑩 Division of Hematology & Oncology
- 王一中 Division of Ophthalmology
- 蔡立威 Division of General Surgery
- Wei-Wu Chen Division of Hematology & Oncology
- 張允中 Division of Radiology
- 羅喬 Division of General Surgery
- 林季宏 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yung-Chang Lin Division of Hematology & Oncology
- Mengting Peng Division of Hematology & Oncology
- Wen-Chi Shen Division of Hematology & Oncology
- Wen-Ling Kuo Division of General Surgery
- Chan-Keng Yang Division of Hematology & Oncology
- 周旭桓 Division of General Surgery
- Chun-Hsiu Liu Division of Ophthalmology
- 沈士哲 Division of General Surgery
- 張潤忠 Division of Radiology
- Chi-Chang Yu Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
850 participants
